<code id='A20F52975E'></code><style id='A20F52975E'></style>
    • <acronym id='A20F52975E'></acronym>
      <center id='A20F52975E'><center id='A20F52975E'><tfoot id='A20F52975E'></tfoot></center><abbr id='A20F52975E'><dir id='A20F52975E'><tfoot id='A20F52975E'></tfoot><noframes id='A20F52975E'>

    • <optgroup id='A20F52975E'><strike id='A20F52975E'><sup id='A20F52975E'></sup></strike><code id='A20F52975E'></code></optgroup>
        1. <b id='A20F52975E'><label id='A20F52975E'><select id='A20F52975E'><dt id='A20F52975E'><span id='A20F52975E'></span></dt></select></label></b><u id='A20F52975E'></u>
          <i id='A20F52975E'><strike id='A20F52975E'><tt id='A20F52975E'><pre id='A20F52975E'></pre></tt></strike></i>

          Home / knowledge / leisure time

          leisure time


          leisure time

          author:focus    Page View:73
          Franklin faces
          Adobe

          ARCH Venture Partners, one of the top investors in the biotech ecosystem, is raising $3 billion for a new fund.

          The Chicago-based firm filed paperwork with the Securities and Exchange Commission this week for what would be its 13th namesake fund. Arch estimated it would raise around $3 billion — roughly the same amount it raised during its more recent fundraising in 2022.

          advertisement

          Arch declined to comment on the new fundraising.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In